Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition"

Circulation. 2016 Jul 19;134(3):e9-e10. doi: 10.1161/CIRCULATIONAHA.116.023086.

Authors

Niwanthi W Rajapakse¹, Sanjaya Kuruppu¹, A Ian Smith¹

Affiliation

¹ From Baker IDI Heart and Diabetes Institute, Melbourne, Australia (N.W.R.); and Department of Biochemistry and Molecular Biology, Biomedical Discovery Institute, Monash University, Clayton, Australia (S.K., A.I.S.).

PMID: 27436888
DOI: 10.1161/CIRCULATIONAHA.116.023086

No abstract available

Publication types

Letter
Comment

MeSH terms

Aminobutyrates
Angiotensin Receptor Antagonists / therapeutic use*
Heart Failure / drug therapy
Humans
Neprilysin*
Receptors, Angiotensin
Tetrazoles / therapeutic use

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Receptors, Angiotensin
Tetrazoles
Neprilysin